Background: Mild cases of atopic dermatitis (AD) generally improve with standard treatment. However, standard treatment fails many patients with recalcitrant AD skin lesions. Study results in animal models have demonstrated that the administration of tea (ie, green, black, or oolong) has suppressed type I and type IV allergic reactions.
Methods:
Patients were asked to maintain their dermatological treatment. However, they were also instructed to drink oolong tea made from a 10-g teabag placed in 1000 mL of boiling water and steeped for 5 minutes. This amount was then divided into 3 equal servings and 1 serving was drunk daily after 3 regular meals. Photographs of 2 or 3 representative lesion sites were taken at baseline and at 1 and 6 months and the severity of pruritus was assessed on a 6-point Lickert-like scale ranging from markedly improved (Ͼ50% improvement) to worsened.
Results: After 1 month of treatment 74 (63%) of the 118 patients showed marked to moderate improvement of their condition. The beneficial effect was first noticed after 1 or 2 weeks of treatment. A good response to treatment was still observed in 64 patients (54%) at 6 months.
Conclusion:
The therapeutic efficacy of oolong tea in recalcitrant AD may well be the result of the antiallergic properties of tea polyphenols.
Arch Dermatol. 2001; 137:42-43 A LTHOUGH STANDARD treatment of atopic dermatitis (AD) is generally effective in mild cases, there are many patients with recalcitrant AD skin lesions for whom standard therapy fails to provide adequate benefit. This may warrant trials of novel treatment of AD. Recent studies [1] [2] [3] [4] in experimental animals showed that oral administration of tea (green, oolong, or black) suppressed both type I and type IV allergic reactions in the skin. We then investigated whether oolong tea has therapeutic effects in recalcitrant AD.
RESULTS
Of the 121 patients enrolled, 118 completed the study. After 1 month of treatment, a marked or moderate improvement of skin lesions was obtained in 74 (63%) of the 118 patients (Table) . The severity of the disease had no influence on the clinical response. The beneficial effect was first noticed after 1 or 2 weeks of treatment. A good response was still observed in 64 patients (54%) after 6 months of treatment (Figure) . Throughout the study, no patient reported clinical side effects on physical examination or had any abnormalities on routine laboratory tests.
COMMENT
From these results, it seems reasonable to consider that oolong tea affords a substantial benefit in the management of at least some patients with recalcitrant AD.
An understanding of the pharmacological basis for the beneficial effect of oolong tea in AD is limited. Animal studies demonstrated that the polyphenol fraction of tea was mainly responsible for the suppression of passive cutaneous anaphylaxis, 2 and that epigallocatechin gallate, a major component of tea polyphenols, suppressed contact hypersensitivity response. 3 Thus, we conclude that the therapeutic efficacy of oolong tea in AD may well be the result of the antiallergic properties of tea polyphenols. 
PATIENTS AND METHODS

PATIENTS
After obtaining informed consent, 121 patients (mean age, 24 years; age range, 16-58 years) with refractory AD were examined. They had been receiving standard treatment (topical corticosteroids, oral antihistamines, and avoidance of aggravating factors) for at least 6 months at our outpatient clinic. There were 20 mild cases of AD, 74 moderate cases, and 27 severe cases. All patients fulfilled the diagnostic criteria of Hanifin and Rajka. 5 During the course of the study, patients were asked to maintain their dermatological treatments.
METHODS
Patients were enrolled in an open study of drinking oolong tea 3 times daily for 6 months. A commercially available teabag containing 10 g of dried oolong tea leaves (Suntory Ltd, Tokyo, Japan) was placed in 1000 mL of boiling water and steeped for 5 minutes. The oolong tea was divided into 3 parts, and drunk after 3 regular meals. To ensure an objective evaluation of the skin lesions, 2 or 3 representative skin sites with active AD lesions were photographed at baseline, 1 month, and 6 months. An overall assessment of clinical symptoms was performed by comparing the photographs of the AD lesions and the intensity of pruritus at 1 and 6 months after treatment. The assessment was graded as symptoms markedly improved (Ͼ50% improvement), moderately improved (25%-50% improvement), slightly improved (Ͻ25% improvement), unchanged, or worsened.
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